Global Therapeutic Drug Monitoring Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Therapeutic Drug Monitoring Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Therapeutic drug monitoring (TDM), a clinical laboratory technology that measures drug concentrations to regulate drug dosage, has become an important treatment aid in both inpatient and ambulatory care. TDM laboratory methods, including immunoassay (EIA, FIA, and RIA) and chromatographic techniques, used to assay blood, urine, and saliva samples of patients taking therapeutic drugs; TDM is also useful in identifying abused drugs.

Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient"s bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects.

According to our (Global Info Research) latest study, the global Therapeutic Drug Monitoring market size was valued at US$ 2045 million in 2023 and is forecast to a readjusted size of USD 3621 million by 2030 with a CAGR of 8.6% during review period.

Global therapeutic drug monitoring key players include Roche, Danaher and Abbott.The top 5 accounts for 60% of the revenue. By region, North America had the highest share of income, reaching 45 percent.In terms of product, blood test is the largest segment, with a share over 70%. And in terms of application, the largest application is hospital labs, followed by independent clinical laboratories.

This report is a detailed and comprehensive analysis for global Therapeutic Drug Monitoring market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Therapeutic Drug Monitoring market size and forecasts, in consumption value ($ Million), 2019-2030

Global Therapeutic Drug Monitoring market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Therapeutic Drug Monitoring market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Therapeutic Drug Monitoring market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Therapeutic Drug Monitoring

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Therapeutic Drug Monitoring market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Danaher, Abbott, Thermo Fisher Scientific, Siemens Healthineers, Bio-Rad Laboratories, bioMerieux, Bühlmann Laboratories, Randox Laboratories, Sekisui Medical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Therapeutic Drug Monitoring market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Therapeutic Drug Monitoring market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Blood Test
Urine Test
Saliva Test

Market segment by Application
Hospital Labs
Independent Clinical Laboratories
Others

Market segment by players, this report covers
Roche
Danaher
Abbott
Thermo Fisher Scientific
Siemens Healthineers
Bio-Rad Laboratories
bioMerieux
Bühlmann Laboratories
Randox Laboratories
Sekisui Medical

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Therapeutic Drug Monitoring product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Therapeutic Drug Monitoring, with revenue, gross margin, and global market share of Therapeutic Drug Monitoring from 2019 to 2024.

Chapter 3, the Therapeutic Drug Monitoring competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Therapeutic Drug Monitoring market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Therapeutic Drug Monitoring.

Chapter 13, to describe Therapeutic Drug Monitoring research findings and conclusion.